B precursor type acute leukaemia

1 trials MedDRA PT
1 Registered trials
0 Recruiting
1 Unique sponsors
2 Unique IMPs
1 Commercial trials
Drug classes (ATC)
— ATC code not specified 1
Mechanism of action (INN-stem analysis)
Kinase inhibitor 1 substance
Antimetabolite 1 substance
Phase I/II: 1

Filter these 1 trials by country, sponsor, date range and more.

Open in Search → Gap analysis →
Show: 1 trials

Phase I/II

1 trial
  • Novartis Pharma AG Commercial
    ASCIMINIB HYDROCHLORIDE; METHOTREXATE
    2025-522019-40-00 7 countries n=21 Orphan
    Pending
Sponsor activity
SponsorTypeTrialsPhasesRecruiting
Novartis Pharma AG Commercial 1 Phase I/II 0
← All indication landscapes